Keywords: Obesity, Type 2 diabetes, GLP-1RA, Incretin therapy, Pharmacotherapy for obesity, Weight management, GLP1/GIP dual agonists, GLP-1/Glucagon dual agonists, GLP1/GIP/Glucagon triple agonists, Metabolism, Energy expenditure, Insulin secretion Introduction Obesity and type 2 diabetes (T2DM) are two of the most common noncommunicable diseases (NCDs) in the world
L-Glutamine: Aids in fat burning and helps with muscle recovery, especially after exercise, while also supporting digestive health
Light exposure, particularly UV light, can degrade peptides over time
Peptides like BPC-157 and TB-500 have become key players in functional and regenerative medicine
Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion